tiprankstipranks
Trending News
More News >
Artelo Biosciences Inc (ARTL)
NASDAQ:ARTL
US Market

Artelo Biosciences (ARTL) Financial Statements

Compare
546 Followers

Artelo Biosciences Financial Overview

Artelo Biosciences's market cap is currently $2.42M. The company's EPS TTM is $; its P/E ratio is -0.10; Artelo Biosciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Mar 23Aug 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -11.40M$ -10.11M$ -9.93M$ -10.29M$ -7.44M
EBITDA$ -12.54M$ -10.11M$ -9.93M$ -10.08M$ -7.44M
Net Income$ -12.88M$ -9.83M$ -9.29M$ -10.08M$ -7.44M
Balance Sheet
Cash & Short-Term Investments$ 600.00K$ 2.34M$ 10.43M$ 17.53M$ 10.06M
Total Assets$ 2.80M$ 4.70M$ 13.04M$ 20.42M$ 12.63M
Total Debt$ 693.00K$ 104.00K$ 23.00K$ 63.00K$ 95.00K
Net Debt$ 93.00K$ -2.23M$ -2.79M$ -6.83M$ -6.53M
Total Liabilities$ 4.07M$ 1.84M$ 1.29M$ 1.02M$ 593.00K
Stockholders' Equity$ -1.27M$ 2.86M$ 11.75M$ 19.40M$ 12.04M
Cash Flow
Free Cash Flow$ -8.52M$ -8.35M$ -8.21M$ -8.01M$ -6.14M
Operating Cash Flow$ -8.52M$ -8.35M$ -8.21M$ -8.01M$ -6.14M
Investing Cash Flow$ -62.00K$ 7.77M$ 3.51M$ 2.96M$ -3.44M
Financing Cash Flow$ 6.87M$ 112.00K$ 567.00K$ 0.00$ 14.11M
Currency in USD

Artelo Biosciences Earnings and Revenue History

Artelo Biosciences Debt to Assets

Artelo Biosciences Cash Flow

Artelo Biosciences Forecast EPS vs Actual EPS